Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Grand Rapids. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Grand Rapids at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic castration resistant prostate cancer (mCRPC) who have received prior anti-cancer treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this study is to learn if the study drug, \[225Ac\]Ac-PSMA-R2, is safe and tolerable, and has anti-tumor activity in treated patients.
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this prostate cancer clinical trial in Grand Rapids, MI
If you're searching for prostate cancer treatment options in Grand Rapids, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Grand Rapids research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.